Skip to main content
Springer logoLink to Springer
. 2022 Dec 2;23(12):1877–1878. doi: 10.1007/s11864-022-01038-z

Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies

Jingqin Zhong 1, Wangjun Yan 1, Chunmeng Wang 1, Wanlin Liu 1, Xinyi Lin 1, Zijian Zou 1, Wei Sun 1,, Yong Chen 1,
PMCID: PMC9767990  PMID: 36459337

Correction to: Current Treatment Options in Oncology (2022) 23:1503-1521

10.1007/s11864-022-01006-7

The original version of this article, unfortunately, contained mistakes.

The author list was arranged incorrectly. The correct sequence of authors is presented below:

Jingqin Zhong, MD

Wangjun Yan, PhD

Chunmeng Wang, PhD

Wanlin Liu, MD

Xinyi Lin, MD

Zijian Zou, MD

Wei Sun, PhD*

Yong Chen, PhD*

*Email: Yong Chen, chenyong@fudan.edu.cn; Wei Sun, wsun14@fudan.edu.cn

Acknowledgements

Jingqin Zhong would like to extend his sincere gratitude to his supervisor, Yong Chen, for his instructive advice and useful suggestions on Jingqin Zhong's thesis. He is deeply grateful of his help in the completion of this thesis. High tribute shall be paid to Wei Sun, whose profound knowledge of English triggers Jingqin Zhong's love for research. He is also deeply indebted to all the other contributors. Finally, Jingqin Zhong is indebted to his parents for their continuous support and encouragement.

Declarations

Conflict of Interest

This work was supported by Shanghai Science and Technology Development Funds (19411951700), the Lingang Laboratory (Grant No. LG-QS-202205-11), and the national natural science foundation of China (81802636).

JZ wrote and edited this manuscript and created tables and figure. JZ, ZZ, WS, WY, CW, WL, XL, and YC reviewed and revised the manuscript. WS and YC provided direction and guidance throughout the preparation of the manuscript. All authors read and approved the final manuscript.

The original article has been corrected.

Footnotes

The online version of the original article can be found at 10.1007/s11864-022-01006-7.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Wei Sun, Email: wsun14@fudan.edu.cn.

Yong Chen, Email: chenyong@fudan.edu.cn.


Articles from Current Treatment Options in Oncology are provided here courtesy of Springer

RESOURCES